CSB
SRPT icon

City State Bank’s Sarepta Therapeutics SRPT Stock Holding History

City State Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10
Closed -$1K – 697
2023
Q3 		$1K Hold
10
– – ﹤0.01% 677
2023
Q2 		$1K Hold
10
– – ﹤0.01% 687
2023
Q1 		$1K Hold
10
– – ﹤0.01% 669
2022
Q4 		$1K Hold
10
– – ﹤0.01% 643
2022
Q3 		$1K Hold
10
– – ﹤0.01% 646
2022
Q2 		$1K Hold
10
– – ﹤0.01% 650
2022
Q1 		$1K Hold
10
– – ﹤0.01% 663
2021
Q4 		$1K Buy
+10
New +$855 ﹤0.01% 654

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

City State Bank's SRPT Position: Q4 2023 in Review

City State Bank sold out of Sarepta Therapeutics (SRPT) in Q4 2023, closing a stake of 10 shares — an estimated $1K sold.

City State Bank first reported a position in SRPT in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q3 2023. 395 funds tracked by Wall St. Rank hold SRPT as of Q4 2023.

  • City State Bank reported no remaining Sarepta Therapeutics position as of Q4 2023 after selling out during the quarter.
  • City State Bank sold 10 Sarepta Therapeutics shares in Q4 2023, an estimated $1K.
  • City State Bank first reported a position in Sarepta Therapeutics in Q4 2021 and held it in 8 quarters.
  • City State Bank's Sarepta Therapeutics position peaked at $1K in Q3 2023.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2023.

Based on City State Bank's 13F filing for Q4 2023, filed 10 Jan 2024.